Page last updated: 2024-10-29

indomethacin and Leukemia, Myelomonocytic, Acute

indomethacin has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Höhler, T1
Teuber, G1
Wanitschke, R1
Meyer zum Büschenfeld, KH1

Other Studies

1 other study available for indomethacin and Leukemia, Myelomonocytic, Acute

ArticleYear
Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.
    The Clinical investigator, 1994, Volume: 72, Issue:10

    Topics: Amphotericin B; Diabetes Insipidus, Nephrogenic; Diuresis; Female; Humans; Indomethacin; Kidney; Leu

1994